Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : National Institute of Public Health and Environment (RIVM, the Netherlands)

Femme et Homme Max 99 ans
National Institute of Public Health and Environment (RIVM, the Netherlands) MAJ Il y a 4 ans

Study to determine the appropriate age for a second immunization with the Meningococcal C conjugated vaccine - To assess serum MenC-PS specific IgG levels at T0 (prior to vaccination) and at 1 month (T1) and 1 year (T2) after the second MenCC vaccination and determine whether there is a difference in IgG lev...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations

Femme et Homme Max 99 ans
National Institute of Public Health and Environment (RIVM, the Netherlands) MAJ Il y a 4 ans

Second meningococcal vaccination in Dutch children: Study to compare the tetravalent MenACWY-TT conjugate vaccine with the monovalent MenC-TT conjugate vaccine. Tweede meningokokken vaccinatie bij nederlandse kinderen: Een onderzoek waarbij het tetravelente MenACWY-TT vaccin vergeleken zal worden met het monovalente MenC-TT vaccin The primary objective is to demonstrate non-inferiority of SBA levels against MenC at 1 year (T2) after vaccination in the group vaccinated with tetravalent MenACWY-TT vaccine as compared with the gro...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations